Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

HCP INVESTOR ALERT: Hagens Berman Reminds HCP, Inc. (NYSE: HCP) Investors of July 11, 2016 Lead Plaintiff Deadline

DOC

SAN FRANCISCO, May 26, 2016 (GLOBE NEWSWIRE) --

The following statement is being issued by Hagens Berman Sobol Shapiro LLP:

To: All persons or entities who purchased or otherwise acquired securities of HCP, Inc. (“HCP” or the “Company”) (NYSE:HCP) between March 30, 2015 and February 8, 2016.

You have until July 11, 2016 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

If you suffered $200,000 or more in losses in HCP, contact Hagens Berman Sobol Shapiro LLP partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing HCP@hbsslaw.com or visiting https://www.hbsslaw.com/cases/HCP.

The litigation concerns Defendants’ statements, in part, about the financial condition of the Company’s largest tenant, ManorCare, and about assurances to  investors that assets HCP acquired from ManorCare and revenue stream from its leases with ManorCare were secure and unimpaired.

In addition, it concerns Defendants’ statements that ManorCare had “a long history of compliance with regulations” in contrast with the fact that the Department of Justice’s lawsuit against ManorCare claiming it submitted over $6 billion dollars in false claims for government reimbursements.

When HCP first disclosed, on May 5, 2015, that its ManorCare assets were impaired by $478 million, HCP’s stock declined by 2.9%.

Then, when HCP disclosed on November 3, 2015 that its equity interest in ManorCare was impaired by $27 million HCP’s stock declined by 2.6%.

Finally, when HCP disclosed on February 9, 2016 that its ManorCare equity interest was worth nothing and its ManorCare assets were impaired by an additional $836 million, HCP’s stock price declined 17%.

“HCP’s ManorCare-related problems were clearly material to HCP investors, who should have been – but were not – fully informed of them,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding HCP should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email HCP@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact: Reed Kathrein, 510-725-3000

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today